HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53 (original) (raw)

References

• Arbuthnot P, Capovilla A and Kew M . (2000). J. Gastroenterol. Hepatol., 15, 357–368.
• Beasley RP, Hwang LY, Lin CC and Chien CS . (1981). Lancet, 2, 1129–1133.
• Becker SA, Lee TH, Butel JS and Slagle BL . (1998). J. Virol., 72, 266–272.
• Benn J and Schneider RJ . (1994). Proc. Natl. Acad. Sci. USA, 91, 10350–10354.
• Bieche I and Lidereau R . (1995). Genes Chromosomes Cancer, 14, 227–251.
• Brison O . (1993). Biochem. Biophys. Acta, 1155, 25–41.
• Chirillo P, Pagano S, Natoli G, Puri PL, Burgio VL, Balsano C and Levrero M . (1997). Proc. Natl. Acad. Sci. USA, 94, 8162–8167.
• Diao J, Garces R and Richardson CD . (2001). Cytokine Growth Factor Rev., 12, 189–205.
• Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A . (1992). Nature, 356, 215–221.
• Dragani TA, Manenti G, Farza H, Dela Porta G, Tiollais P and Pourcel C . (1990). Carcinogenesis, 11, 953–956.
• Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, Will H and Harris CC . (1997). Proc. Natl. Acad. Sci. USA, 94, 14707–14712.
• Feitelson MA, Zhu M, Duan LX and London WT . (1993). Oncogene, 8, 1109–1117.
• Ganem D and Varmus HE . (1987). Ann. Rev. Biochem., 56, 651–693.
• Gluzman Y . (1981). Cell, 23, 175–182.
• Goetz F, Tzeng YJ, Guhl E, Merker J, Graessmann M and Graessmann A . (2001). Oncogene, 20, 2325–2332.
• Gottlob K, Fulco M, Levrero M and Graessmann A . (1998b). J. Biol. Chem., 273, 33347–33353.
• Gottlob K, Pagano S, Levrero M and Graessmann A . (1998a). Cancer Res., 58, 3566–3570.
• Graessmann A and Graessmann M . (1983). Methods Enzymol., 101, 482–492.
• Huo TI, Wang XW, Forgues M, Wu CG, Spillare EA, Giannini C, Brechot C and Harris CC . (2001). Oncogene, 20, 3620–3628.
• Jehn B, Costello E, Marti A, Keon N, Deane R, Li F, Friis RR, Burri PH, Martin F and Jaggi R . (1992). Mol. Cell Biol., 12, 3890–3902.
• Joo M, Kang YK, Kim MR, Lee HK and Jang JJ . (2001). Liver, 21, 89–95.
• Kim H, Lee H and Yun Y . (1998). J. Biol. Chem., 273, 381–385.
• Kohzato N, Dong Y, Sui L, Masaki T, Nagahata S, Nishioka M, Konishi R and Tokuda M . (2001). Hepatol. Res., 21, 27–39.
• Krause D, Lyons A, Fennelly C and O'Connor R . (2001). J. Biol. Chem., 276, 19244–19252.
• Kumar V, Jayasuryan N and Kumar R . (1996). Proc. Natl. Acad. Sci. USA, 93, 5647–5652.
• Lee T-H, Elledge SJ and Butel JS . (1995). J. Virol., 69, 1107–1114.
• MacDonald RJ, Swift GH, Pryzybyla AE and Chirgwin JM . (1987). Methods Enzymol, 152, 219–227.
• Madden CR, Finegold MJ and Slagle BL . (2000). J. Virol., 74, 5266–5272.
• Murakami S . (1999). Intervirology, 42, 81–99.
• Natoli G, Avantaggiati ML, Chirillo P, Puri PL, Ianni A, Balsano C and Levrero M . (1994). Oncogene, 9, 2837–2843.
• Pollicino T, Terradillos O, Lecoeur H, Gougeon ML and Buendia MA . (1998). Biomed. Pharmacother., 52, 363–368.
• Sambrook J, Fritsch EF and Maniatis T . (1989). Molecular Cloning, A Laboratory Manual. 2nd edn. Cold Spring Harbor (NY) Laboratory Press: New York.
  Google Scholar
• Santarelli R, Tzeng YJ, Zimmermann C, Guhl E and Graessmann A . (1996). Oncogene, 12, 495–505.
• Siegel PM, Hardy WR and Muller WJ . (2000). Bioessays, 22, 554–563.
• Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D and Brechot C . (1999). Oncogene, 18, 4848–4859.
• Slagel BL, Lee T-H, Medina D, Finegold MJ and Butel JS . (1996). Mol. Carcinog., 15, 261–269.
• Su F and Schneider RJ . (1997). Proc. Natl. Acad. Sci. USA, 94, 8744–8749.
• Su F, Theodosis CN and Schneider RJ . (2001). J. Virol., 75, 215–225.
• Terradillos O, Billet O, Renard CA, Levy R, Molina T, Briand P and Buendia MA . (1997). Oncogene, 14, 395–404.
• Terradillos O, de La Coste A, Pollicino T, Neuveut C, Sitterlin D, Lecoeur H, Gougeon ML, Kahn A and Buendia MA . (2002). Oncogene, 21, 377–386.
• Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P and Buendia MA . (1998). Oncogene, 17, 2115–2123.
• Tzeng YJ, Guhl E, Graessmann M and Graessmann A . (1993). Oncogene, 8, 1965–1971.
• Tzeng YJ, Zimmermann C, Guhl E, Berg B, Avantaggiati ML and Graessmann A . (1998). Oncogene, 16, 2103–2114.
• Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA and Jay G . (1995). Nat. Genet., 9, 41–47.
• Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, Hoeijmakers JH and Harris CC . (1995). Cancer Res., 55, 6012–6016.

Download references